<DOC>
	<DOCNO>NCT02125175</DOCNO>
	<brief_summary>High dose radiotherapy effective treatment prostate cancer . However , increase risk side effect compare low dose radiotherapy . This study investigate use dose painting radiotherapy . Dose paint radiotherapy administers high dose radiotherapy area cancer inside prostate lower ( standard ) dose rest prostate . This may improve control cancer without increase side effect . The radiotherapy give 20 dos , call fraction .</brief_summary>
	<brief_title>BIOPROP20 : Biologically Optimised IMRT Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts Tumour Nodules Men With Intermediate High Risk Prostate Cancer</brief_title>
	<detailed_description>For patient prostate cancer spread , typical treatment hormone therapy radiotherapy . It possible identify area within prostate contain significant amount cancer functional MRI 18F choline PET CT scan . These area call Dominant Intraprostastic Lesions 'DILs ' . Targeted prostate biopsy help confirm scan result . The radiotherapy dose DILs increase , whilst rest prostate treat standard dose . This technique call dose painting 'boost ' Intensity Modulated Radiotherapy Treatment ( IMRT ) . IMRT give 37 treatment dos call fraction , day 8 week . A hypofractionated schedule administration total radiotherapy treatment small number fraction , high dose per fraction . Recent evidence suggest idea use 'hypofractionated ' treatment schedule well convenient similar number side effect regular schedule . In study , 50 patient intermediate/high risk prostate cancer suitable fit radical radiotherapy recruit . The patient undergo stag functional MRI scan , fiducial marker insertion ( require image guide radiotherapy ) hormone therapy per standard care treatment . The choline PET CT scan target prostate biopsy optional . They useful MRI difficult interpret offer patient felt appropriate clinician . After 2 month hormone therapy ( standard protocol ) patient CT /MRI plan scan undergo IMRT 20 treatment ( fraction ) .The patient follow 24 month start radiotherapy treatment . The main aim assess side effect relate bladder bowel 18 week ( acute toxicity ) start hypofractionated IMRT .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Histologically confirm adenocarcinoma prostate 2 . NCCN intermediate/high risk disease estimate risk lymph node involvement 15 40 % * 3 . MRI stage T2aT4 N0M0 4 . Age 1880 year 5 . Normal blood count ( Hb &gt; 11g/dl , WBC &gt; 4000/mm3 , platelet &gt; 100,000/mm3 ) 6. WHO performance status 0 1 7 . Fully inform write consent Risk pelvic lymph node involvement = ( Gleason score 6 ) x 10 + 2/3 PSA 1 . Prior radiotherapy prostate pelvis 2 . Prior hormone therapy radical prostatectomy 3 . Total hip replacement 4 . Clinically significant inflammatory bowel disease 5 . Contraindication diagnostic MRI scan 6 . Unable general anaesthetic 7 . Anticoagulant therapy temporarily stop</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>